Sexual Dysfunction Related To Psychiatric Disorders - A Systematic Review
Sexual Dysfunction Related To Psychiatric Disorders - A Systematic Review
Published in:
Journal of Sexual Medicine
DOI:
10.1093/jsxmed/qdad074
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2023
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
The publication may also be distributed here under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license.
More information can be found on the University of Groningen website: https://www.rug.nl/library/open-access/self-archiving-pure/taverne-
amendment.
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Abstract
Background: Sexual dysfunction is thought to be highly prevalent in patients with psychiatric disorders. Factors such as the use of psychotropic
substances (ie, psychopharmaceuticals and drugs), age, or somatic diseases may contribute to sexual problems, but the extent to which
psychopathology itself affects sexual functioning is not well understood.
Aim: The study sought to provide an overview of the literature on the prevalence of sexual dysfunction in psychotropic-free and somatic disease-
free psychiatric patients.
Method: A systematic review (PRISMA [Preferred Reporting Items for Systematic Reviews and Meta-Analyses]) was conducted by 2 authors
(TH and AWMP) independently, with the review process being monitored by a third author. Relevant articles on the relationship between sexual
dysfunctions and psychopathology were searched in PubMed, Web of Science, and PsycINFO from inception until June 16, 2022. The study
methods were entered in the international register of systematic reviews PROSPERO (2021, CRD42021223410).
Outcomes: The main outcome measures were sexual dysfunction and sexual satisfaction.
Results: Twenty-four studies were identified, including a total of 1199 patients. These studies focused on depressive disorders (n = 9 studies),
anxiety disorders (n = 7), obsessive- compulsive disorder (OCD) (n = 5), schizophrenia (n = 4), and posttraumatic stress disorder (n = 2). No
studies on bipolar disorder were found. Reported prevalence rates of sexual dysfunction in psychiatric disorders were 45% to 93% for depressive
disorders, 33% to 75% for anxiety disorders, 25% to 81% for OCD, and 25% for schizophrenia. The most affected phase of the sexual response
cycle was sexual desire, in both men and women with depressive disorders, posttraumatic stress disorder, and schizophrenia. Patients with
OCD and anxiety disorders most frequently reported dysfunction in the orgasm phase, 24% to 44% and 7% to 48%, respectively.
Clinical Implications: The high prevalence of sexual dysfunction requires more clinical attention by means of psychoeducation, clinical guidance,
sexual anamnesis, and additional sexological treatment.
Strengths and Limitations: This is the first systematic review on sexual dysfunction in psychotropic-free and somatic disease–free psychiatric
patients. Limitations include the small number of studies, small sample sizes, the use of multiple questionnaires (some not validated), which
may contribute to bias.
Conclusion: A limited number of studies identified a high prevalence of sexual dysfunction in patients with a psychiatric disorder, with substantial
variation between patient groups in frequency and phase of reported sexual dysfunction.
Received: December 13, 2022. Revised: May 3, 2023. Accepted: May 6, 2023
© The Author(s) 2023. Published by Oxford University Press on behalf of The International Society of Sexual Medicine. All rights reserved. For permissions,
please e-mail: [email protected]
966 The Journal of Sexual Medicine, 2023, Vol 20, Issue 7
Year of Country Subtype Sample Age (y)a,b Sex (% Study design Comparison Classifica- Measures for Measures for Total score Funding
publica- disorder size female) group tion for diagnosis and sexual function quality
tion disorder severity of assessment
disorder
Depressive disorders
Mathew and 1982 Unites States of — 51 29.6 (8.5)b 69 Case-control Healthy control N/A BDI 7-point Likert-type 5c N/A
Weinman52 America subjects scale of symptoms
of sexual
dysfunctions
Angst16 1998 Switzerland Untreated 122 28-35a N/A Longitudinal — N/A Semi-structured Semi-structured 1d N/A
depression interview interview
Kennedy et al61 1999 Canada MDD 134 38.8 (11.5)b 59 Cross-sectional — DSM-IV HAMD-17 SFQ 5d N/A
NEO-PI-R
Frohlich and 2002 United States of — 47 24.55 (5.12)b 100 Case control Nondepressed N/A BDI BISF-W 5c N/A
Meston48 America
Cheng et al63 2007 Hong Kong — 22 69 (10)b 0 Cross-sectional — N/A GDS IIEF-15 6d N/A
Kendurkar et al41 2008 Australia MDD 50 34.3 (9.2)b 38 Case-control Healthy control DSM-IV HAMD-17 ASEX 7c None
subjects
Thakurta et al44 2012 Indian MDD 60 38 (10.5)b 60 Cross-sectional — DSM-IV HAMD-17 ASEX 4d None
Hamzaoui et al47 2016 Tunisia — 30 37.64 (N/A)b 100 Cross-sectional — DSM- IV HAMD FSFI 4d None
Sreelakshmy et al46 2017 India MDD 40 37.7 (N/A)a 100 Cross-sectional — DSM-IV SCID-I FSFI 6d None
HAMD
Anxiety disorders
Van Minnen and 2000 The Netherlands PD with 27 33.7 (10.2)b 100 Case-control Healthy control N/A N/A QSD 4c N/A
Kampman43 agoraphobia subjects MMQ
Figueira et al45 2001 Brasil PD 28 36.46 (11.38)b 50 Cross-sectional - DSM-IV SCID-I DSM-IV criteria 2d N/A
SAD 30 34.39 37 (excluding “C”
34.39 (7.39)b criteria)
Bodinger et al53 2002 Israel Social phobia 41 Men: 41 Case-control Healthy control DSM-IV SCID-P Questionnaire on 4c Grant by Sarah
31.5 (7.5)b subjects LSAS sexual functioning and Moshe
Women: (n = 20) + hospitalized of Schiavi Mayer
31.4 (7.4)b patients for minor foundation
operations (n = 20) (Switzerland)
Mercan et al54 2006 Turkey PD 12 34.7 (8.08)b 100 Case-control Healthy control DSM-IV BDI ASEX 4c none
subjects BAI
PAS
Kendurkar et al41 2008 Australia GAD 50 34.3 (9.2)b 36 Case-control Healthy control DSM-IV HAMA ASEX 8c None
subjects
Aksoy et al42 2012 Croatia PD 40 38.11 (8.64)b N/A Case-control Healthy control DSM-IV SCID-I GRISS 1c N/A
subjects
Dèttore et al55 2013 Italy PD and GAD 30 30.17 (5.96)b 100 Case-control Healthy control DSM-IV STAI FSFI 4c N/A
subjects ASI SES
SIS
Obsessive-compulsive disorder
Freund and 1989 United States of — 44 32 (N/A)b 57 Cross-sectional — DSM-III MOCI 9-point Likert-type 0d Grant by
Steketee49 America CAC scale National
Institute of
Mental Health
No.
R01MH31634
(Continued)
The Journal of Sexual Medicine, 2023, Vol 20, Issue 7
Year of Country Subtype Sample Age (y)a,b Sex (% Study design Comparison Classifica- Measures for Measures for Total score Funding
publica- disorder size female) group tion for diagnosis and sexual function quality
tion disorder severity of assessment
disorder
Van Minnen and 2000 The Netherlands — 17 31.6(6.9)b 100 Case-control Healthy control N/A N/A QSD 4c N/A
Kampman43 subjects MMQ
Kendurkar et al41 2008 Australia — 50 34.3 (9.2)b 44 Case-control Healthy control DSM-IV YBOCS ASEX 8c None
subjects
Aksoy et al42 2012 Croatia — 40 34.17 (7.62)b N/A Case-control Healthy control DSM-IV SCID-I GRISS 1c None
subjects
Ghassemzadeh 2017 Iran — 56 Men 64 Cross-sectional — DSM-IV MOCI FSFI (in Persian, not 3d None
et al51 35.2 (5)b OCI-R validated)
Women IIEF (in Persian, not
33.19 (7.71)b validated)
Posttraumatic stress disorder
Kotler et al56 2000 Israel — 15 39.8 (7.4)b 0 Case-control Healthy control N/A SCL-90 Questionnaire on 3c N/A
subjects IES sexual functioning
of Schiavi
Hirsch57 2009 United States of — 53 35 (N/A)b 0 Cross-sectional — N/A PCL (military Self-designed 1d None
America version) questionnaire on
sexual functioning
The Journal of Sexual Medicine, 2023, Vol 20, Issue 7
Psychotic disorders
Aizenberg et al58 1995 Israel Schizophrenia 20 35.26 (6.61)b 0 Case-control Healthy control DSM-III-R N/A Questionnaire on 3c Supported by
subjects sexual functioning Emouna
of Schiavi Foundation
(Germany)
Kockott and 1996 Germany Schizophrenia 12 18-65a N/A Case-control Dermatological DSM-III-R BPRS Semi-structured 1c Supported by
Pfeiffer50 patients ICD-9 interview Wilhelm-
Sander-Stiftung
(Germany)
Dembler-Stamm 2017 Germany Schizophrenia 19 25.4 (4.0)b 11 Case-control Healthy control DSM-IV SCID-I DISF-SR 7c Supported by
et al62 subjects ICD-10 Charité
University
Hospital Berlin
(Germany)
Düring et al60 2019 Denmark Schizophrenia 59 24.7 (6.1)b 36 Cross-sectional — ICD-10 PANSS UKU 7d Grant by
CDSS Sexual anamnesis Mental Health
Services
(Denmark) and
by grant
R25-A2701
from the
Lundbeck
Foundation
Del Cacho et al59 2020 Spain First-episode 68 24.4 (9.22)b 35 Case-control Healthy control N/A PANSS CSFQ 5c Supported by
psychosis subjects Parc Sanitari
Sant Joan de
Déu (PSSJD)
(Spain)
Abbreviations: ASEX, Arizona Sexual Experience Scale; ASI, Anxiety Sensitivity Index; BAI, Beck Anxiety Inventory; BDI, Beck Depression Inventory; BISF-W, Brief Index of Sexual Functioning for Women; BPRS,
Brief Psychiatric Rating Scale; CAC, compulsive activity checklist; CDSS, Calgary Depression Scale in Schizophrenia; CSFQ, Change in Sexual Functioning Questionnaire; ED, erectile dysfunction; DISF-SR, Derogatis
Inventory in Sexual Function Self Report; FSFI, Female Sexual Function Index; GAD, generalized anxiety disorder; GDS, Geriatric Depression Scale; GRISS, Golombok-Rust Sexual Satisfaction Inventory; HAMA,
Hamilton Anxiety Rating Scale; HAMD, Hamilton Depression Rating Scale; IES, Impact of Event Scale; IIEF, International Index of Erectile Function; LSAS, Liebowitz Social Anxiety Scale; MDD, major depressive
disorder; MMQ, Maudsley Marital Questionnaire; MOCI, Maudsley Obsessional Compulsive Inventory; N/A, •••; NEO-PI-R, Revised NEO Personality Inventory; OCI-R, Obsessive Compulsive Inventory–Revised;
PANSS, Positive and Negative Syndrome Scale; PAS, Panic and Agoraphobia Scale; PCL, PTSD Checklist; PD, panic disorder; QSD, Questionnaire for Screening Sexual Dysfunctions; SAD, social anxiety disorder;
SCID-I, Structured Clinical Interview for DSM-IV Axis I Disorders; SCID-P, Structured Clinical Interview for DSM-IV Axis I Disorders–Patient Version; SCL-90, Symptom Check List-90; SFQ, Sexual Functioning
969
Questionnaire; STAI, State–Trait Anxiety Inventory version Y; UKU, Udvalg for Kliniske Undersøgelse; Y-BOCS, Yale-Brown Obsessive Compulsive Scale; N/A, not applicable. a Range. b Mean (SD). c Quality
assessment case-control studies: very low risk of bias = 8 points, low risk of bias = 6-7 points, medium risk of bias = 4-5 points, high risk of bias = 0-3 points. d Quality assessment cross-sectional studies: very low
risk of bias = 9-10 points, low risk of bias = 7-8 points, medium risk of bias = 5-6 points, high risk of bias = 0-4 points.
Downloaded from https://academic.oup.com/jsm/article/20/7/965/7190127 by Rijksuniversiteit Groningen user on 05 December 2023
970
(Continued)
The Journal of Sexual Medicine, 2023, Vol 20, Issue 7
lubrication.
Aksoy et al42 — — — Women: Higher prevalence of
24% anorgasmia dissatisfaction.
Ghassemzadeh et al51 Men: Men: Men: Men: Men:
25% sexual dysfunction 10% low desire 20% ED 25% orgasmic dysfunction 40% less intercourse
Women: Women: Women: Women satisfaction
81% sexual dysfunction 50% low desire 58% problems regarding 44% orgasmic dysfunction Women:
arousal, 42% less satisfaction
36% less lubrication
Posttraumatic stressdisorder Kotler et al56 — Significantly poorer sexual Significantly poorer sexual Significantly poorer sexual Significantly poorer sexual
function in desire function arousal and orgasmic function function satisfaction)
compared with the control compared with the control
group. group.
Hirsch57 — 74% diminished desire 49% ED 15% reported ejaculatory —
delay or incompetence
Schizophrenia Aizenberg et al58 — Reduced frequency of sexual Reduced degree of coital More PE. —
fantasies, lower frequency of erections and more erectile
desire, and more lack of problem during intercourse.
desire.
Kockott and Pfeiffer50 25% patients and 13% of the — — — —
control group reported sexual
problems.
Dembler-Stamm et al62 — Significantly more problems No significant difference on Significant more problems —
regarding sexual cognitions sexual arousal compared with regarding orgasm compared
and fantasies compared with control subjects. with control subjects.
control subjects.
Düring et al60 — Men: Men: Men: —
18% increased desire, 7% ED 15% ejaculatory dysfunction
45% decreased desire Women: Women:
Women: 14% decreased lubrication 26% orgasmic dysfunction
24% increased desire,
19% decreased desire
Del Cacho et al59 Significantly poorer overall Significantly poorer sexual — — —
sexual functioning in patients desire in patients than healthy
than healthy control subjects. control subjects.
971
Abbreviations: ED, erectile dysfunction; HSDD, hypoactive sexual desire disorder; OCD, obsessive-compulsive disorder; OR, odds ratio; PE, premature ejaculation.
Downloaded from https://academic.oup.com/jsm/article/20/7/965/7190127 by Rijksuniversiteit Groningen user on 05 December 2023
972 The Journal of Sexual Medicine, 2023, Vol 20, Issue 7
arousal.58,62 The third study found that female patients expe- Discussion
riencing schizophrenia showed a more decreased arousal in The research on sexual dysfunction in psychiatric patients
comparison with male patients.60 For details, see Table 2. without the use of psychotropic medication, drugs, and
somatic comorbidity is limited. When categorized in diag-
nostic subgroups, a prevalence of sexual dysfunction was
Orgasm found in 45% to 93% for patients with depressive disorder,
Sixteen studies reported on orgasmic dysfunction. In order in 33% to 75% for patients with anxiety disorders, in 25% to
of declining prevalence per psychiatric disorder, overall 81% for OCD, and in 25% for schizophrenia. The prevalence
orgasmic dysfunction was found in 24% to 44% of patients of overall sexual dysfunction for PTSD was not reported in
with OCD (2 studies), in 7% to 48% of patients with the identified studies. The most commonly reported sexual
anxiety disorders (3 studies), in 15% to 26% of patients problem among both men and women was decreased sexual
with schizophrenia (1 study), in 11% to 22% of patients desire. Orgasm difficulties were most frequently reported
with a depressive disorder (2 studies), and in 15% of in patients with OCD, and to a lesser extent in patients
patients with PTSD.41,42,44,45,51,53,57,60,61 For details, with anxiety disorders (eg, a decreased ability to achieve an
see Table 2). orgasm and/or a decreased quality of their orgasm). Lower
sexual satisfaction was reported in patients with a depressive
disorder, anxiety disorder, OCD, and PTSD, whereas this
Satisfaction outcome was not available for patients with schizophrenia. It
Eight studies reported on sexual satisfaction. Seven studies is striking that no articles were found on patients with bipolar
reported reduced sexual satisfaction (in 2 studies in depressive disorder, while lifetime impairment of sexual function and
disorders, 2 studies on anxiety disorders, and 1 study on promiscuity is significantly more common in patients with
patients with PTSD).48,51,53,56,63 For OCD patients, 40% bipolar disorder than in control subjects.64 The findings of
to 73% of the patients reported less sexual satisfaction (2 our study are in accordance with previous articles suggesting
studies) and higher prevalence of dissatisfaction (1 study), that psychiatric disorders are often associated with decreased
in contrast to 1 study that found no significant difference sexual functioning.14,18,20
between patients with OCD and control subjects.41,42,49,51 Variations in reported sexual dysfunction both within and
For details, see Table 2). between psychiatric disorders may have been influenced by
The Journal of Sexual Medicine, 2023, Vol 20, Issue 7 973
lack of a standardized assessment tool, differences in assess- A significant number of reviewed studies had small sample
ment tools, diagnostic criteria, differences in demographic sizes and were of a heterogeneous nature.74 Based on the
characteristics, and sample sizes used in the studies. Also, lack quality assessment of the included studies, most were classified
of knowledge on the prediagnosis sexual dysfunction prior as poor quality, which restricts the ability to draw definitive
to developing a psychiatric disorder could be a confounding conclusions from these studies (Table 2). Furthermore, 11 of
factor.49 Furthermore, the severity of the psychiatric disorder 24 studies that were included had no control group.
and the impact of comorbid psychiatric disorders may have Third, many different scales measuring sexual function
also contributed to the observed variability in sexual dysfunc- were used, making it difficult to compare study results. Studies
tion.43,44,63 used semi-structured interviews, self-designed questionnaires,
The literature hypothesizes on possible common pathways and clinical impressions to quantify sexual function, some-
15. Sørensen T, Giraldi A, Vinberg M. Sexual distress and quality of 33. Pizzol D, Demurtas J, Stubbs B, et al. Relationship
life among women with bipolar disorder. Int J Bipolar Disord. between cannabis use and erectile dysfunction: a
2017;5(1):29. https://doi.org/10.1186/s40345-017-0098-0. systematic review and meta-analysis. Am J Mens Health.
16. Angst J. Sexual problems in healthy and depressed persons. 2019;13(6):1557988319892464. https://doi.org/10.1177/155798
Int Clin Psychopharmacol. 1998;13(Suppl 6):S1–S4. https://doi.o 8319892464.
rg/10.1097/00004850-199807006-00001. 34. Cao S, Gan Y, Dong X, Liu J, Lu Z. Association of quantity and
17. de Boer MK, Castelein S, Wiersma D, Schoevers RA, Kneg- duration of smoking with erectile dysfunction: a dose-response
tering H. The facts about sexual (dys)function in schizophre- meta-analysis. J Sex Med. 2014;11(10):2376–2384. https://doi.o
nia: an overview of clinically relevant findings. Schizophr Bull. rg/10.1111/jsm.12641.
2015;41(3):674–686. https://doi.org/10.1093/schbul/sbv001. 35. Peugh J, Belenko S. Alcohol, drugs and sexual function: a
18. Vulink NC, Denys D, Bus L, Westenberg HG. Sexual pleasure review. J Psychoactive Drugs. 2001;33(3):223–232. https://doi.o
with and without depressive symptoms. Perspect Psychiatr Care. depression. J Sex Med. 2009;6(11):3063–3070. https://doi.o
2017;53(3):208–213. https://doi.org/10.1111/ppc.12160. rg/10.1111/j.1743-6109.2009.01455.x.
52. Mathew RJ, Weinman ML. Sexual dysfunctions in depression. 65. Cyranowski JM, Frank E, Cherry C, Houck P, Kupfer DJ.
Arch Sex Behav. 1982;11(4):323–328. https://doi.org/10.1007/ Prospective assessment of sexual function in women treated
BF01541593. for recurrent major depression. J Psychiatr Res. 2004;38(3):
53. Bodinger L, Hermesh H, Aizenberg D, et al. Sexual function and 267–273.
behavior in social phobia. J Clin Psychiatry. 2002;63(10):874–879. 66. Baranowski AM, Noll AK, Golder S, Markert C, Stark R. Effects
https://doi.org/10.4088/jcp.v63n1004. of depression on processing and evaluation of sexual stimuli in
54. Mercan S, Karamustafalioglu O, Ayaydin EB, et al. Sexual dys- women. J Sex Med. 2022;19(3):441–451.
function in female patients with panic disorder alone or with 67. Bird ER, Piccirillo M, Garcia N, Blais R, Campbell S. Relationship
accompanying depression. Int J Psychiatry Clin Pract. 2006;10(4): between posttraumatic stress disorder and sexual difficulties: a